Editing Food and Drug Administration (section)

===International Cooperation===
In February 2011, President [[Barack Obama]] and Canadian Prime Minister [[Stephen Harper]] issued a "Declaration on a Shared Vision for Perimeter Security and Economic Competitiveness"<ref>{{cite press release |url=https://obamawhitehouse.archives.gov/the-press-office/2011/02/04/joint-statement-president-obama-and-prime-minister-harper-canada-regul-0 |title=Joint Statement by President Obama and Prime Minister Harper of Canada on Regulatory Cooperation |date=February 4, 2011 |access-date=February 26, 2011 |archive-date=January 22, 2017 |archive-url=https://web.archive.org/web/20170122200817/https://obamawhitehouse.archives.gov/the-press-office/2011/02/04/joint-statement-president-obama-and-prime-minister-harper-canada-regul-0 |via=[[NARA|National Archives]] |work=[[whitehouse.gov]] |url-status=live}}</ref><ref>{{cite press release |url=http://www.pm.gc.ca/eng/media.asp?id=3931 |title=PM and U.S. President Obama announce shared vision for perimeter security and economic competitiveness between Canada and the United States |publisher=Prime Minister of Canada |date=February 4, 2011 |access-date=February 26, 2011 |archive-url=https://web.archive.org/web/20110219142120/http://www.pm.gc.ca/eng/media.asp?id=3931 |archive-date=February 19, 2011}}</ref> and announced the creation of the Canada-United States Regulatory Cooperation Council (RCC) "to increase regulatory transparency and coordination between the two countries."<ref name=OPM1>{{cite press release |date=December 7, 2011 |url=http://pm.gc.ca/eng/media.asp?id=4511 |publisher=Office of the Prime Minister of Canada |title=United States-Canada Regulatory Cooperation Council (RCC) Joint Action Plan: Developing and implementing the Joint Action Plan |archive-url=https://web.archive.org/web/20130729152814/http://pm.gc.ca/eng/media.asp?id=4511 |archive-date=July 29, 2013}}</ref>

Under the RCC mandate, the FDA and [[Health Canada]] undertook a "first of its kind" initiative by selecting "as its first area of alignment common cold indications for certain over-the-counter [[antihistamine]] ingredients (GC 2013-01-10)."<ref name=GC20130110>{{cite web |publisher=Government of Canada |series=Canada's Action Plan |title=Notice: Regulatory Cooperation Council (RCC) Over-the-Counter (OTC) Products: Common Monograph Working Group: Selection of a Monograph for Alignment |url=http://actionplan.gc.ca/en/page/rcc-ccr/notice-regulatory-cooperation-council-rcc-over |date=January 10, 2013 |access-date=February 15, 2013 |archive-url=https://web.archive.org/web/20141108070216/http://actionplan.gc.ca/en/page/rcc-ccr/notice-regulatory-cooperation-council-rcc-over |archive-date=November 8, 2014}}</ref>

A more recent example of the FDA's international work is their 2018 cooperation with regulatory and law-enforcement agencies worldwide through [[Interpol]] as part of Operation Pangea XI.<ref>{{Cite web |url=https://www.interpol.int/News-and-media/News/2018/N2018-123 |title=N2018-123 / 2018 / News / News and media / Internet / Home - INTERPOL |website=[[Interpol.int]] |access-date=February 8, 2019 |archive-date=February 9, 2019 |archive-url=https://web.archive.org/web/20190209123957/https://www.interpol.int/News-and-media/News/2018/N2018-123}}</ref><ref>{{Cite web |url=https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm624070.htm |title=Press Announcements - FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids | author = Office of the Commissioner |publisher=Food and Drug Administration |access-date=February 8, 2019 |archive-date=February 7, 2019 |archive-url=https://web.archive.org/web/20190207132558/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm624070.htm |url-status=live}}</ref> The FDA targeted 465 websites that illegally sold potentially dangerous, unapproved versions of [[opioid]], [[Chemotherapy|oncology]], and [[Antiviral drug|antiviral]] prescription drugs to U.S. consumers. The agency focused on [[money laundering|transaction laundering]] schemes in order to uncover the complex online drug network.<ref>{{Cite web |url=https://www.thepaypers.com/expert-opinion/transaction-laundering-in-2019-time-to-review-the-monitoring-strategy/776727 |title=Transaction laundering in 2019 – time to review the monitoring strategy |publisher=The Paypers |access-date=February 8, 2019 |archive-date=July 14, 2020 |archive-url=https://web.archive.org/web/20200714025734/https://thepaypers.com/expert-opinion/transaction-laundering-in-2019-time-to-review-the-monitoring-strategy/776727 |url-status=live}}</ref>